LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 45 pages found matching Zetia- Vytorin Liver Damage and Heart Attack Risk
Vytorin , a drug prescribed to treat high cholesterol, is a combination of the cholesterol-lowering Zetia and the statin Zocor. Since its FDA approval in 2004, serious Vytorin side effects have been reported, including Vytorin liver problems and statin cardiomyopathy , which can lead to Vytorin heart attack. Furthermore, the ENHANCE study in 2008 showed... - Vytorin Fraudulent Marketing Class Action Lawsuit
The makers of the cholesterol drug Vytorin are under fire for allegedly making false claims in their marketing campaign. New York Attorney-General Andrew Cuomo is investigating whether Vytorin's marketing campaign violated the state's laws regarding false advertising. Specifically, officials are concerned that, despite results from a study that found Vytorin... - Zetia and Vytorin Continue to be Controversial
Aug-28-17 Washington, DC: There is little doubt that the cholesterol-fighting drug Zetia (ezetimibe) has travelled a rocky road since it was first approved by the US Food and Drug Administration (FDA) in 2002. And while several years have passed since the controversial delay in releasing study results into potential Zetia side effects , issues involving Zetia and... - Vytorin Brightens with IMPROVE-IT, but Vytorin Lawsuits Remain
Mar-27-15 San Diego, CA The folks at Merck & Co. and their Vytorin partner Schering-Plough Corp. can be forgiven if they are enjoying the re-birth of Vytorin and the accompanying optimism after enduring the scorn that accompanied the delayed release of the ENHANCE study in 2008. The most recent “IMPROVE-IT” study was designed to foster a better outc... - Zetia and Vytorin: Never Say Never
Jan-29-15 Washington, DC If there is one thing to be said about pharmaceutical companies, it remains that they never, ever give up. Not until a product is deemed so unsafe that it is physically pulled from the market, will a manufacturer finally wave the white flag. This is especially true in the statin sector, which is the biggest piece of the pie with potential to... - Study Finds Benefit to Vytorin, but Is It Credible?
Nov-20-14 Chicago, IL A study released today suggests that Vytorin , a drug that combines Zetia and Zocor, is more effective than Zetia alone at preventing heart attack and other heart-related health problems. The study is good news for Merck, who has been under fire for its handling of Vytorin. But other previous studies gave conflicting results regarding Vytori... - Medical Industry Waits for Study on Vytorin
Oct-29-14 Washington, DC Less than a month away is the expected deadline for the medical world to hear the results of a study on Vytorin . The study has been undertaken to add to the published literature about Vytorin side effects and Vytorin effectiveness. So far, at least two studies regarding the drug, which combines ezetimibe (Zetia) and simvastatin (Zocor),... - New Vytorin Study Results on the Way
Sep-27-14 Washington, DC Another study is set to be released regarding the effectiveness of Vytorin , a drug that combines ezetimibe (known by the brand name Zetia) and simvastatin (known by the brand name Zocor). Whether the study will confirm previous findings that question the effectiveness of combining Zetia and Zocor is not known. Some previous studies have... - Of All Vytorin Side Effects, Potential for Cancer Is Getting Traction
Aug-31-14 Washington, DC One can’t help but forgive anyone filing a Vytorin lawsuit, due to not only the potential for various harms related to possible Vytorin side effects , but to the very culture that sees drugs such as these approved in the first place. Vytorin, as most familiar with the file are aware, is a combination of two drugs: Zetia (ezetimib... - Ezetrol Heart Attack and Stroke Legal Help
Merck and Shering-Plough have announced that, based on a study of 720 patients, Vytorin, which combines Zetia (Ezetimibe) and Zocor (Simvastatin), does not reduce the growth of fatty arterial plaque. Rather, patients who took Vytorin had more plaque growth than patients who took only Zocor. In Canada, the drug Zetia is known as Ezetrol and is developed, m... - Critics Question Liptruzet
May-5-13 Washington, DC Even though Liptruzet has only just been introduced on the market, at least one critic is questioning why the drug received approval. Liptruzet is a combination of Lipitor and Zetia, but Steven Nissen, of the Cleveland Clinic, says that because Zetia has not been proven to prevent heart attacks and strokes, approving it in combination with a... - $688M Settlements Reached in Vytorin and Zetia ENHANCE Securities Class Actions
New York, NY: Settlements totalling $688 million have been reached in the securities class actions pending against Merck & Co. Inc. ("Merck"), Schering-Plough Corporation ("Schering"), Merck/Schering-Plough Pharmaceuticals, certain of the Companies' directors and officers, and the underwriters of a 2007 Schering stock offering. The settlements, rea... - Zocor Side Effects
The Zocor cholesterol drug, a member of the class of drugs known as statins, is prescribed to many people with high cholesterol when diet and exercise are inadequate. Since 2002, the FDA has issued warnings about Zocor liver damage and increased Zocor myopathy (muscle damage) associated with statins. A recent Zocor SEARCH study shows that higher doses o... - Zetia and/or Statins: The Good, the Bad and the Ugly
Apr-14-11 Halle-Wittenberg, Germany Can a drug designed to curb heart attacks also cause heart attacks in some people? Apparently, it's possible with statins or medication like Zetia when used in combination with a statin. Statins are designed to lower the "bad" cholesterol thought to be a contributing factor for heart attack and stroke, while leaving the so-cal... - Zetia heart attack may result in lawsuit
Zetia , an anti-hyperlipidemic drug, is prescribed to treat high cholesterol. Since its FDA approval in 2002, serious Zetia side effects have been reported, including Zetia liver and Zetia heart attack problems. These Zetia problems have led to a number of Zetia lawsuits . Zetia is also used in conjunction with statins to lower cholesterol, but it has... - Will We Be Left Waiting for Latest Vytorin Trial Results?
Apr-12-11 Whitehouse Station, NJ It's been awhile since Vytorin has been in the news. The hybrid drug that combines statins Zetia (ezetimibe) and Zocor (simvastatin) into one medication was thought to improve cardiovascular performance through the reduction of plaque accumulations on arterial walls—specifically, atherosclerosis in the carotid artery, locat... - Niacin Found to Be More Effective than Vytorin at Lowering Cholesterol
Nov-26-09 Orlando, FL According to a recent study from the New England Journal of Medicine, generic B vitamin Niacin was found to be more effective at reducing levels of arterial plaque than Vytorin or Zetia. The limited study of 208 patients found that those who used ezetimibe, the active ingredient in Vytorin and Zetia, experienced greater risk of health atta... - ARBITER 6-HALTS Results Not Good for Zetia
Nov-17-09 Houston, TX Results of the ARBITER 6-HALTS trial of Zetia (ezetimibe) and Niaspan (niacin) show that Niaspan is more effective than Zetia as a cholesterol treatment. This news has caused some doctors to question whether or not to use Zetia to treat patients with high cholesterol. The results were published along with two editorials in the New England... - Vytorin and Zetia Setback
Nov-15-09 Washington, DC How well do Vytorin and Zetia work? According to a new study released today, possibly not at all. Doctors are now questioning whether these two blockbuster cholesterol drugs should even be prescribed. This new study found that ezetimibe, the active ingredient in both Vytorin and Zetia, is significantly less effective at reducin... - Merck, Schering Settle Vytorin Zetia Class Action
Merck and Schering Plough have entered into $41.5 million settlement of class action lawsuits related to claims against their shared cholesterol medication Vytorin and Zetia. The suit revolved around allegations that the results from the Enhance Trial raised questions about the efficacy of the Zetia and Vytorin. The settlement will resolve approxi...